Across TCGA pan-cancer cohorts, RNU2-32P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU2-32P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RNU2-32P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU2-32P is over-expressed in tumor, although a few such as HNSC and THCA show the opposite, repressed pattern.

COAD, LUSC, and HNSC are the cancer types where RNU2-32P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-32P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.205	.025	2	view →
LUSC	Female	All	+0.131	.041	1	view →
HNSC	All	II,III,IV	−0.107	.045	1	view →
THCA	Female	II,III,IV	−0.100	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU2-32P RNA expression & survival · all RNU2-32P data types